PGY-2 Medication-Use Safety & Policy

PGY-2 Medication-Use Safety & Policy


The Pharmacy Department at Memorial Sloan Kettering recognizes the value and need for a medication-use safety & policy residency for pharmacists seeking a career in medication-use safety or drug policy.


PGY2 pharmacy residency training build on the foundation of pharmacy practice established during Doctor of Pharmacy (PharmD) education and the PGY1 pharmacy residency experience. The MSK PGY2 medication-use safety and policy residency provides residents with a 52-week learning experiences that is designed to prepare residents to assume a leadership role to implement sustained medication-use and quality improvement strategies in adult and pediatric patients. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience. Residents who successfully complete an accredited PGY2 residency should possess competencies that qualify them for advanced medication safety leadership positions.


The program offers a diverse experience designed to develop the resident’s skills in medication safety principles, leadership, process improvement, drug information, institutional policy development, planning, and research.

The resident will be prepared to assume a leadership position to implement sustained medication-use and quality improvement strategies and manage formulary and drug policies for adult and pediatric patients. The resident will use our fully integrated electronic medical record and a library of comprehensive drug guidelines for virtually all medications used in cancer patients. The resident will also utilize our robust electronic reporting system to dissect actual events and trend improvement efforts that enhance the care of our patients. The resident will interact with our experienced pharmacy staff that operates in one of the country’s most comprehensive pharmacy systems, including a large team of clinical pharmacy specialists. The resident will also learn about the medication use challenges in one of the world’s most extensive investigational drug programs with an NCI- supported research pharmacy. The resident will attend several interdisciplinary institutional committees, including Pharmacy and Therapeutics, Pharmacy Quality Assessment, and Medication Management. The resident will learn how to be a confident presenter by delivering monthly didactic presentations, including medication safety pearls, journal clubs, and pharmacy grand rounds programs.

Required Longitudinal Learning Experiences:

  • Medication Safety Leadership
  • Drug Policy I
  • Medication Event Analysis
  • Pharmacy Operations: Breast and Imaging Center
  • Investigational Drug Service (IDS)
  • Research Project

Required Block Rotations:

  • Pharmacy Orientation
  • Pharmacy Operations: Koch Center
  • Institute for Safe Medication Practices (ISMP)
  • Materials Management I & II
  • Adult Critical Care Medicine (ICU)
  • Geriatrics
  • Pediatric Oncology
  • Supportive Care Service
  • Transitions of Care
  • Well-being and Resilience 

Application Deadline

January 14th

Length of Program

One year

Number of Positions



  • Successful completion of an ACPE accredited Doctor of Pharmacy program
  • Successful completion of an ASHP accredited PGY-1 Pharmacy Practice Residency
  • Eligibility for pharmacist licensure in New York State (Residents are required to obtain Pharmacist licensure in the State of New York by November 1st)
  • Completion of an on-site or virtual interview
  • Interview in the Personal Placement Service (PPS) at ASHP Midyear Clinical Meeting (encouraged, not required)

How to Apply

Interested candidates should submit the following through Pharmacy Online Residency Centralized Application (PhORCAS):

  • Letter of interest explaining career goals
  • Three letters of recommendation (standard PhORCAS format)
  • Academic transcript
  • Curriculum Vitae

Additional Information

Frequently Asked Questions
Residency Program Preceptors
Residency Learning Experiences and Teaching Activities


Amelia Chan, PharmD, MBA, MS, BCOP
Assistant Director, Drug Policy Management, Quality, & Safety Medication-Use Safety and Policy PGY-2 Residency Program Director
Memorial Sloan Kettering Cancer Center
321 E 61st St, Room 566
New York, NY 10065
[email protected]